556 related articles for article (PubMed ID: 12696368)
1. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
du Châtelet IP; Alonso JM; Taha MK
Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
3. The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso.
Njanpop-Lafourcade BM; Parent du Châtelet I; Sanou O; Alonso JM; Taha MK
Microbes Infect; 2005 Apr; 7(4):645-9. PubMed ID: 15823512
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.
Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S
Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090
[TBL] [Abstract][Full Text] [Related]
5. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
[TBL] [Abstract][Full Text] [Related]
6. [Which vaccination strategies for African meningococcal meningitis?].
Saliou P; Debois H
Bull Soc Pathol Exot; 2002 Dec; 95(5):326-30. PubMed ID: 12696369
[TBL] [Abstract][Full Text] [Related]
7. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
Vogel G
Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
[No Abstract] [Full Text] [Related]
8. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002.
Koumaré B; Ouedraogo-Traoré R; Sanou I; Yada AA; Sow I; Lusamba PS; Traoré E; Dabal M; Santamaria M; Hacen MM; Kaboré AB; Caugant DA
Vaccine; 2007 Sep; 25 Suppl 1():A37-41. PubMed ID: 17521783
[TBL] [Abstract][Full Text] [Related]
9. Clonal spread of serogroup W135 meningococcal disease in Turkey.
Kilic A; Urwin R; Li H; Saracli MA; Stratton CW; Tang YW
J Clin Microbiol; 2006 Jan; 44(1):222-4. PubMed ID: 16390974
[TBL] [Abstract][Full Text] [Related]
10. Increase in Neisseria meningitidis serogroup W135, Niger, 2010.
Collard JM; Maman Z; Yacouba H; Djibo S; Nicolas P; Jusot JF; Rocourt J; Maitournam R
Emerg Infect Dis; 2010 Sep; 16(9):1496-8. PubMed ID: 20735947
[No Abstract] [Full Text] [Related]
11. The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt.
Zombré S; Hacen MM; Ouango G; Sanou S; Adamou Y; Koumaré B; Kondé MK
Vaccine; 2007 Sep; 25 Suppl 1():A69-71. PubMed ID: 17630052
[TBL] [Abstract][Full Text] [Related]
12. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.
von Gottberg A; du Plessis M; Cohen C; Prentice E; Schrag S; de Gouveia L; Coulson G; de Jong G; Klugman K;
Clin Infect Dis; 2008 Feb; 46(3):377-86. PubMed ID: 18181736
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
[TBL] [Abstract][Full Text] [Related]
14. Emergence of W135 meningococcal meningitis in Ghana.
Forgor AA; Leimkugel J; Hodgson A; Bugri A; Dangy JP; Gagneux S; Smith T; Pluschke G
Trop Med Int Health; 2005 Dec; 10(12):1229-34. PubMed ID: 16359402
[TBL] [Abstract][Full Text] [Related]
15. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso.
Decosas J; Koama JB
Lancet Infect Dis; 2002 Dec; 2(12):763-5. PubMed ID: 12467693
[TBL] [Abstract][Full Text] [Related]
16. Meningitis epidemics in Africa: a brief overview.
Teyssou R; Muros-Le Rouzic E
Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
[TBL] [Abstract][Full Text] [Related]
17. Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan.
Nicolas P; Ait M'barek N; Al-Awaidy S; Al Busaidy S; Sulaiman N; Issa M; Mahjour J; Mölling P; Caugant DA; Olcén P; Santamaria M
APMIS; 2005 Mar; 113(3):182-6. PubMed ID: 15799761
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal vaccine in travelers.
Wilder-Smith A
Curr Opin Infect Dis; 2007 Oct; 20(5):454-60. PubMed ID: 17762777
[TBL] [Abstract][Full Text] [Related]
19. Molecular surveillance of meningococcal meningitis in Africa.
Caugant DA; Nicolas P
Vaccine; 2007 Sep; 25 Suppl 1():A8-11. PubMed ID: 17521785
[TBL] [Abstract][Full Text] [Related]
20. ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study.
Sié A; Pflüger V; Coulibaly B; Dangy JP; Kapaun A; Junghanss T; Pluschke G; Leimkugel J
Trop Med Int Health; 2008 Jun; 13(6):861-8. PubMed ID: 18384478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
